Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Prevention of Alcohol Withdrawal
NCT01937364Phase 2Terminated
- Sponsor
- Essentia Health
- Start
- Nov 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of baclofen in alcohol withdrawal syndrome (AWS), sponsored by Essentia Health. Started Nov 2013; status: terminated.
02
Drugs
baclofen
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT01937364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937364.